Retrieve available abstracts of 21 articles: HTML format
Single Articles
July 2025
SAIDOUNE F, Lee D, Di Domizio J, Le Floc'h C, et al Enhanced TLR7-dependent production of type I interferon by pDCs underlies
pandemic chilblains.
J Exp Med. 2025;222:e20231467. PubMedAbstract available
MATZ HC, Ellebedy AH Vaccination against influenza viruses annually: Renewing or narrowing the
protective shield?
J Exp Med. 2025;222:e20241283. PubMedAbstract available
June 2025
GROEN K, Kuratli R, Enkelmann J, Fernbach S, et al Type I interferon autoantibody footprints reveal neutralizing mechanisms and
allow inhibitory decoy design.
J Exp Med. 2025;222:e20242039. PubMedAbstract available
MADSEN A, Okba NMA, Pholcharee T, Matz HC, et al Identification of a seasonal influenza vaccine-induced broadly protective
neuraminidase antibody.
J Exp Med. 2025;222:e20241930. PubMedAbstract available
January 2025
VALERI E, Kajaste-Rudnitski A Antiviral immunity lassoed down by excess RNA.
J Exp Med. 2025;222:e20241743. PubMedAbstract available
December 2024
BELLOS E, Santillo D, Vantourout P, Jackson HR, et al Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome
in children (MIS-C).
J Exp Med. 2024;221:e920240699. PubMedAbstract available
October 2024
JEGER-MADIOT R, Planas D, Staropoli I, Debarnot H, et al Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA
vaccine boosting.
J Exp Med. 2024;221:e20240289. PubMedAbstract available
September 2024
ZANONI I Kids' noses resist COVID-19.
J Exp Med. 2024;221:e20241027. PubMedAbstract available
WATKINS TA, Green AB, Amat JAR, Cheemarla NR, et al High burden of viruses and bacterial pathobionts drives heightened nasal innate
immunity in children.
J Exp Med. 2024;221:e20230911. PubMedAbstract available
CHAN YH, Lundberg V, Le Pen J, Yuan J, et al SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency.
J Exp Med. 2024;221:e20231725. PubMedAbstract available
FERNBACH S, Mair NK, Abela IA, Groen K, et al Loss of tolerance precedes triggering and lifelong persistence of pathogenic type
I interferon autoantibodies.
J Exp Med. 2024;221:e20240365. PubMedAbstract available
August 2024
MCINTIRE KM, Meng H, Lin TH, Kim W, et al Maturation of germinal center B cells after influenza virus vaccination in
humans.
J Exp Med. 2024;221:e20240668. PubMedAbstract available
July 2024
MACLEAN AJ, Bonifacio JPPL, Oram SL, Mohsen MO, et al Regulation of pulmonary plasma cell responses during secondary infection with
influenza virus.
J Exp Med. 2024;221:e20232014. PubMedAbstract available
June 2024
WU TT, Travaglini KJ, Rustagi A, Xu D, et al Interstitial macrophages are a focus of viral takeover and inflammation in
COVID-19 initiation in human lung.
J Exp Med. 2024;221:e20232192. PubMedAbstract available
February 2024
BASTARD P, Gervais A, Taniguchi M, Saare L, et al Higher COVID-19 pneumonia risk associated with anti-IFN-alpha than with anti-IFN-omega
auto-Abs in children.
J Exp Med. 2024;221:e20231353. PubMedAbstract available
November 2023
RUTERBUSCH MJ, Hondowicz BD, Takehara KK, Pruner KB, et al Allergen exposure functionally alters influenza-specific CD4+ Th1 memory cells in
the lung.
J Exp Med. 2023;220:e20230112. PubMedAbstract available
September 2023
WANG Z, Muecksch F, Raspe R, Johannsen F, et al Memory B cell development elicited by mRNA booster vaccinations in the elderly.
J Exp Med. 2023;220:e20230668. PubMedAbstract available
August 2023
RYBKINA K, Bell JN, Bradley MC, Wohlbold T, et al SARS-CoV-2 infection and recovery in children: Distinct T cell responses in MIS-C
compared to COVID-19.
J Exp Med. 2023;220:e20221518. PubMedAbstract available
LIN YS, Chang YC, Chao TL, Tsai YM, et al The Src-ZNRF1 axis controls TLR3 trafficking and interferon responses to limit
lung barrier damage.
J Exp Med. 2023;220:e20220727. PubMedAbstract available
GILBERTSON B, Subbarao K Mammalian infections with highly pathogenic avian influenza viruses renew
concerns of pandemic potential.
J Exp Med. 2023;220:e20230447. PubMedAbstract available
May 2023
GARCIA-GARCIA A, Perez de Diego R, Flores C, Rinchai D, et al Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic
COVID-19 pneumonia.
J Exp Med. 2023;220:e20220170. PubMedAbstract available